Arkolith/Insider Trading/BEAM/Form 4

Ciaramella Giuseppe

PresidentBeam Therapeutics Inc. (BEAM) · full profile →Form 4 · filed Jun 22, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)7K$0.67$4K225K
Jun 17, 2026Option exercise(M)29K$1.03$30K254K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)7K—$00
Jun 17, 2026Option exercise(M)29K—$057K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-277509) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML